Fisher & Paykel Healthcare Corporation Limited (FPH) Ratios
Fisher & Paykel Healthcare Corporation Limited Ratios
AU:FPH's free cash flow for Q4 2026 was $296.60M. For the 2026 fiscal year, AU:FPH's free cash flow was decreased by $-120.80M and operating cash flow was $417.40M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.31 | 1.87 | 1.83 | 2.67 | 2.92 |
| Quick Ratio | 1.66 | 1.18 | 1.00 | 1.41 | 1.74 |
| Cash Ratio | 0.93 | 0.53 | 0.21 | 0.42 | 0.30 |
| Solvency Ratio | 0.85 | 0.74 | 0.47 | 0.77 | 1.11 |
| Operating Cash Flow Ratio | 1.33 | 1.10 | 1.12 | 0.82 | 1.07 |
| Short-Term Operating Cash Flow Coverage | 90.85 | 8.57 | 5.47 | 56.71 | 61.19 |
| Net Current Asset Value | $ 414.00M | $ 254.46M | $ 182.30M | $ 323.10M | $ 460.60M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.06 | 0.08 | 0.07 | 0.05 |
| Debt-to-Equity Ratio | 0.07 | 0.08 | 0.11 | 0.08 | 0.06 |
| Debt-to-Capital Ratio | 0.06 | 0.08 | 0.10 | 0.08 | 0.06 |
| Long-Term Debt-to-Capital Ratio | 0.02 | 0.00 | 0.02 | 0.04 | 0.04 |
| Financial Leverage Ratio | 1.35 | 1.35 | 1.30 | 1.26 | 1.25 |
| Debt Service Coverage Ratio | 37.65 | 6.55 | 2.74 | 32.66 | 46.84 |
| Interest Coverage Ratio | 64.76 | 43.30 | 13.98 | 49.96 | 103.90 |
| Debt to Market Cap | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Interest Debt Per Share | 0.27 | 0.26 | 0.35 | 0.26 | 0.19 |
| Net Debt to EBITDA | -0.38 | -0.18 | 0.29 | 0.06 | 0.02 |
| Profitability Margins | |||||
| Gross Profit Margin | 64.16% | 62.88% | 60.28% | 59.54% | 61.70% |
| EBIT Margin | 28.52% | 25.22% | 14.44% | 21.07% | 31.00% |
| EBITDA Margin | 35.30% | 30.80% | 20.94% | 27.30% | 36.84% |
| Operating Profit Margin | 28.52% | 25.22% | 14.47% | 21.07% | 31.00% |
| Pretax Profit Margin | 27.00% | 24.90% | 13.41% | 20.65% | 30.70% |
| Net Profit Margin | 20.03% | 18.66% | 7.54% | 15.76% | 22.95% |
| Continuous Operations Profit Margin | 20.03% | 18.66% | 7.54% | 15.76% | 22.95% |
| Net Income Per EBT | 74.19% | 74.95% | 56.26% | 76.31% | 74.75% |
| EBT Per EBIT | 94.68% | 98.76% | 92.65% | 98.00% | 99.04% |
| Return on Assets (ROA) | 16.42% | 14.79% | 5.81% | 11.35% | 17.89% |
| Return on Equity (ROE) | 22.15% | 19.95% | 7.54% | 14.28% | 22.44% |
| Return on Capital Employed (ROCE) | 28.31% | 24.85% | 13.41% | 17.48% | 28.23% |
| Return on Invested Capital (ROIC) | 20.72% | 17.87% | 7.18% | 13.19% | 20.91% |
| Return on Tangible Assets | 16.85% | 15.28% | 6.05% | 11.81% | 18.66% |
| Earnings Yield | 2.13% | 1.78% | 0.88% | 1.78% | 2.79% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.82 | 7.68 | 6.84 | 7.27 | 9.42 |
| Payables Turnover | 14.78 | 14.18 | 21.56 | 14.95 | 11.69 |
| Inventory Turnover | 2.56 | 2.19 | 2.18 | 1.76 | 1.75 |
| Fixed Asset Turnover | 1.66 | 1.51 | 1.31 | 1.38 | 1.71 |
| Asset Turnover | 0.82 | 0.79 | 0.77 | 0.72 | 0.78 |
| Working Capital Turnover Ratio | 4.43 | 5.18 | 4.37 | 2.97 | 3.05 |
| Cash Conversion Cycle | 171.31 | 188.63 | 203.91 | 233.53 | 215.80 |
| Days of Sales Outstanding | 53.49 | 47.52 | 53.40 | 50.20 | 38.76 |
| Days of Inventory Outstanding | 142.51 | 166.86 | 167.45 | 207.74 | 208.26 |
| Days of Payables Outstanding | 24.69 | 25.74 | 16.93 | 24.42 | 31.22 |
| Operating Cycle | 196.00 | 214.37 | 220.85 | 257.95 | 247.02 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.13 | 0.87 | 0.73 | 0.41 | 0.56 |
| Free Cash Flow Per Share | 0.84 | 0.75 | 0.15 | 0.05 | 0.27 |
| Dividend Paid and CapEx Coverage Ratio | 1.56 | 2.04 | 0.89 | 0.59 | 0.82 |
| Capital Expenditure Coverage Ratio | 3.84 | 7.45 | 1.27 | 1.13 | 1.91 |
| Operating Cash Flow Coverage Ratio | 4.54 | 3.58 | 2.27 | 1.63 | 3.11 |
| Operating Cash Flow to Sales Ratio | 0.28 | 0.27 | 0.24 | 0.15 | 0.20 |
| Free Cash Flow Yield | 2.23% | 2.24% | 0.60% | 0.19% | 1.14% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 46.74 | 56.85 | 113.52 | 56.18 | 35.89 |
| Price-to-Sales (P/S) Ratio | 9.38 | 10.50 | 8.56 | 8.85 | 8.24 |
| Price-to-Book (P/B) Ratio | 10.37 | 11.23 | 8.56 | 8.02 | 8.05 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 44.75 | 44.68 | 166.14 | 522.79 | 87.55 |
| Price-to-Operating Cash Flow Ratio | 33.09 | 38.69 | 35.04 | 59.04 | 41.71 |
| Price-to-Earnings Growth (PEG) Ratio | 1.31 | 0.36 | -2.44 | -1.66 | -1.26 |
| Enterprise Value Multiple | 26.20 | 33.92 | 41.17 | 32.48 | 22.38 |
| Enterprise Value | 21.63B | 19.54B | 15.16B | 14.09B | 13.54B |
| EV to EBITDA | 26.20 | 33.92 | 41.17 | 32.48 | 22.38 |
| EV to Sales | 9.25 | 10.45 | 8.62 | 8.87 | 8.24 |
| EV to Free Cash Flow | 44.11 | 44.45 | 167.33 | 523.71 | 87.64 |
| EV to Operating Cash Flow | 32.62 | 38.49 | 35.29 | 59.14 | 41.75 |
| Tangible Book Value Per Share | 3.48 | 2.86 | 2.85 | 2.88 | 2.76 |
| Shareholders’ Equity Per Share | 3.60 | 2.99 | 3.00 | 3.03 | 2.91 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.26 | 0.25 | 0.44 | 0.24 | 0.25 |
| Revenue Per Share | 3.99 | 3.19 | 3.00 | 2.75 | 2.85 |
| Net Income Per Share | 0.80 | 0.60 | 0.23 | 0.43 | 0.65 |
| Tax Burden | 0.74 | 0.75 | 0.56 | 0.76 | 0.75 |
| Interest Burden | 0.95 | 0.99 | 0.93 | 0.98 | 0.99 |
| Research & Development to Revenue | 0.10 | 0.11 | 0.11 | 0.11 | 0.09 |
| SG&A to Revenue | 0.26 | 0.26 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
| Income Quality | 1.42 | 1.45 | 3.24 | 0.95 | 0.86 |
Currency in NZD